Chen Yu, Parvez Faruque, Gamble Mary, Islam Tariqul, Ahmed Alauddin, Argos Maria, Graziano Joseph H, Ahsan Habibul
Departments of Environmental Medicine and Medicine and New York University Cancer Institute, New York University School of Medicine, New York, NY, USA.
Toxicol Appl Pharmacol. 2009 Sep 1;239(2):184-92. doi: 10.1016/j.taap.2009.01.010. Epub 2009 Jan 27.
The contamination of groundwater by arsenic in Bangladesh is a major public health concern affecting 35-75 million people. Although it is evident that high levels (>300 microg/L) of arsenic exposure from drinking water are related to adverse health outcomes, health effects of arsenic exposure at low-to-moderate levels (10-300 microg/L) are not well understood. We established the Health Effects of Arsenic Longitudinal Study (HEALS) with more than 20,000 men and women in Araihazar, Bangladesh, to prospectively investigate the health effects of arsenic predominantly at low-to-moderate levels (0.1 to 864 microg/L, mean 99 microg/L) of arsenic exposure. Findings to date suggest adverse effects of low-to-moderate levels of arsenic exposure on the risk of pre-malignant skin lesions, high blood pressure, neurological dysfunctions, and all-cause and chronic disease mortality. In addition, the data also indicate that the risk of skin lesion due to arsenic exposure is modifiable by nutritional factors, such as folate and selenium status, lifestyle factors, including cigarette smoking and body mass index, and genetic polymorphisms in genes related to arsenic metabolism. The analyses of biomarkers for respiratory and cardiovascular functions support that there may be adverse effects of arsenic on these outcomes and call for confirmation in large studies. A unique strength of the HEALS is the availability of outcome data collected prospectively and data on detailed individual-level arsenic exposure estimated using water, blood and repeated urine samples. Future prospective analyses of clinical endpoints and related host susceptibility will enhance our knowledge on the health effects of low-to-moderate levels of arsenic exposure, elucidate disease mechanisms, and give directions for prevention.
孟加拉国地下水受砷污染是一个重大的公共卫生问题,影响着3500万至7500万人。虽然很明显,饮用水中高浓度(>300微克/升)的砷暴露与不良健康后果有关,但低至中等浓度(10 - 300微克/升)的砷暴露对健康的影响尚不清楚。我们在孟加拉国阿拉伊扎尔建立了砷的健康影响纵向研究(HEALS),对2万多名男性和女性进行研究,以前瞻性地调查主要在低至中等浓度(0.1至864微克/升,平均99微克/升)的砷暴露情况下砷对健康的影响。迄今为止的研究结果表明,低至中等浓度的砷暴露会对癌前皮肤病变风险、高血压、神经功能障碍以及全因和慢性病死亡率产生不良影响。此外,数据还表明,砷暴露导致皮肤病变的风险可因营养因素(如叶酸和硒状态)、生活方式因素(包括吸烟和体重指数)以及与砷代谢相关基因的基因多态性而改变。对呼吸和心血管功能生物标志物的分析支持砷可能对这些结果产生不良影响,这需要在大型研究中得到证实。HEALS的一个独特优势是有前瞻性收集的结局数据以及使用水、血液和重复尿液样本估计的详细个体水平砷暴露数据。未来对临床终点和相关宿主易感性的前瞻性分析将增进我们对低至中等浓度砷暴露对健康影响的了解,阐明疾病机制,并为预防提供指导。